Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma 2Leukemia 2Infections 2Lymphoma, Non-Hodgkin 1

Interventions

Rituximab 4Etoposide 4Whole-Body Irradiation 2Gemcitabine 2Cyclophosphamide 2umbralisib 1ublituximab 1rasburicase 1pegfilgrastim 1fludarabine phosphate 1fludarabine 1epratuzumab 1aldesleukin 1Trimethoprim, Sulfamethoxazole Drug Combination 1Thiotepa 1Radioimmunodetection 1Prednisone 1Oxaliplatin 1Nivolumab 1Melphalan 1Leucovorin 1Lenalidomide 1Immunoglobulins, Intravenous 1Hizentra 1Filgrastim 1Doxorubicin 1Cytarabine 1Ciprofloxacin 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Lymphoma, Non-Hodgkin × Amoxicillin-Potassium Clavulanate Combination × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡